Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

AstraZeneca - Envy

February 07, 2016 | 1:00

A constipated man wanders through a black-and-white discomfort-scape as AstraZeneca-backed "OIC is Different" raises awareness about a side effect of opioid painkillers in a second-quarter spot via BGB Group that wasn't announced before the game. 

"Envy" may have been effective for AstraZeneca, which makes a treatment called Movantik, but the spot introduced a touch of malaise that 2016 Super Bowl advertising had avoided following the "Somber Bowl" of 2015.

Like King Pharmaceuticals' "Heart Attack" in 2007's Super Bowl XLI, AstraZeneca used the game to call attention to a condition without explicitly promoting its treatment, which would trigger FDA requirements to spell out potential side effects (see "Biking" by Flomax and "Be My Baby" by Cialis).

Send credit info to SuperBowlAdArchive@adage.com.
  • BrandAstraZeneca
  • Year2016
  • AgencyBGB Group
  • Superbowl #50
  • Quarter airedQ2